Kezar Life Sciences Inc.

KZR | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.29

$0 (0.00%)

At close: May 11, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $53.86M

Enterprise Value $-15.7M

Beta 0.41

Average Volume 74.38K

Shares Outstanding (Diluted) 7.32M

Shares Change YoY 0.23%

Institutional Ownership 60.91%

Exchange NASDAQ

ISIN US49372L2097

Price Performance

Price Change 1M -1.2%

Price Change 3M 15.0%

Price Change 6M 18.5%

Price Change YTD 15.9%

Price Change 1Y 72.3%

Price Change 3Y -97.5%

Price Change 5Y -98.6%

1M CAGR (ann.) 17.6%

1Y CAGR (ann.) 76.9%

5Y CAGR (ann.) -58.3%

All-Time CAGR -50.1%

Valuation

PE Ratio -0.95

Forward PE N/A

PEG Ratio 0.05

Forward PEG -0.03

PS Ratio N/A

Forward PS 2.60

PB Ratio 0.77

P/FCF Ratio -1.04

P/Adj. FCF Ratio -0.89

P/OCF Ratio -1.27

EV/Sales N/A

EV/EBIT 0.32

EV/EBITDA 0.33

EV/FCF 0.30

Earnings Yield -105.1%

FCF Yield -96.2%

Adj. FCF Yield -112.8%

Financial Health

Net Cash $71.88M

Total Debt $2.33M

Cash & Short-Term Investments $71.88M

Total Assets $76.65M

Current Ratio 24.46

Quick Ratio 24.46

Debt / Equity Ratio 0.02

Debt / EBITDA -0.05

Debt / FCF -0.04

OCF / Debt -22.26

Interest Coverage -50.01

Altman Z-Score -5.15

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -17.3%

Returns

Return on Assets -66.5%

Return on Equity -58.4%

Return on Invested Capital -63.1%

Return on Capital Employed -64.4%

Return on Tangible Assets -66.5%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y 0.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -74.2%

EPS CAGR 5Y -54.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y 22.7%

FCF CAGR 5Y -5.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 7

EPS Growth Next 3Y -0.2%

Revenue Growth Next 3Y N/A

Earnings Date Aug 11, 2026

EPS Estimate (next Q) -$1.05

EPS Growth Est (next Q) -43.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11

Price Target Upside 50.9%

Cash Flow

Operating Cash Flow $-51.78M

Free Cash Flow $-51.79M

Adj. Free Cash Flow $-60.75M

FCF Per Share -$5.72

OCF Per Share -$5.72

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-403K

Operating Income $-52.27M

EBITDA $-48.27M

Net Income $-56.03M

EPS (Diluted) -$7.66

Revenue / Employee N/A

Profit / Employee $-1.02M

Employees 55